UnitedHealth Group (UNH)
$229.49 10.95 (4.55%)
20:00 EDT UNH Stock Quote Delayed 20 Minutes
Previous Close $229.49
Market Cap 220.54B
PE Ratio 20.20
Volume (Avg. Vol.) 4.65M
Day's Range 227.27 - 239.34
52-Week Range 187.72 - 306.71
Dividend & Yield 3.30 (1.44%)
UNH Stock Predictions, Articles, and UnitedHealth Group News
- From InvestorPlace
- From the Web
An interesting fact, courtesy of the ETF Research Center, the price-to-earnings ratio on the SPDR Dow Jones Industrial ETF (NYSEARCA:DIA), the Dow tracking ETF, currently resides in an area that was seen following the fourth-quarter 2018 and May 2019 declines, which eventually gave way to equity market rallies.
Uncertainty in the healthcare sector means that for many investors, UNH stock's dividend just isn't worth it.
Even though they are prone to headlines during elections, here are 3 healthcare stocks to buy: PFE, UNH and JNJ.
Here we looked for five of the Street’s highest-rated Dow Jones stocks right now. As you will see all five of these stocks show a firm ‘Strong Buy’ Street consensus. That's based on all the ratings received by each stock over the last three months.
What goes up must come down sooner or later. After a fantastic run, the Dow Jones is vulnerable to some selling, and these five stocks could get hit.
UnitedHealth earnings for the second quarter of 2019 have UNH stock falling, despite the company's positive results for the period.
In advance of some important earnings reports coming Thursday from some big-name members of the Dow Jones Industrial Average, the major U.S. equity indexes did a whole lot of nothing Wednesday.
The stock charts of HollyFrontier, Activision Blizzard and Vertex Pharmaceuticals are poised to end the trading week in a pivotal situation.
While it appears unlikely that the Fed will lower rates by 50 basis points this month, markets are increasingly comfortable with the notion of 0.25% reduction followed by more of the same in September.
Something that has been discussed here in recent days is the shift away from trade concerns to company-specific issues. That was very much the case today as a slew of big names in the Dow were punished for a variety of stock-specific reasons. Let's have a look at some of those names.
Despite the jitters going into Saturday's G20 meeting, the Dow Jones today was aided by a decent earnings report before the bell from WBA.
PFE, JNJ and UNH are three healthcare stocks to buy even up near all-time market highs. Each for its own reasons.
Long-term investors can find some solace with an article in Barron's today indicating Dow 30,000 could arrive sooner than expected.
Dow Jones stocks usually are coveted by investors. Here are 7 stocks to buy that look like the index's best choices for the rest of 2019.
While the Federal Reserve did not cut rates, stocks were still feeling optimistic. Several big names were up in the Dow Jones today.
A judge is challenging the CVS Health-Aetna deal and the drug store sector is out of favor. So when will the discount on CVS stock end?
Comments from President Trump regarding Mexico potentially avoiding trade tariffs set to go into effect next week were among the catalysts for stocks today. Trump is pushing Mexico to buy more from U.S. farmers, saying that if Mexico cooperates, tariffs could be avoided.
One of the best mutual funds last year was the T. Rowe Price Health Sciences Fund. Here are 7 healthcare stocks to buy from its holdings.
Investors are punishing Bristol-Myers on the markets more than they should. BMY stock's acquisition of Celgene isn't the only reason.
First, is the opportunity cost of patiently holding UNH stock when it’s obviously facing severe headwinds, worth it? After all, there are so many other stocks you could buy with better near-term prospects.
From Market News Video
Navellier RatingsPowered by Portfolio Grader